Global Next Generation Cancer Diagnostic Devices Market Research Report 2022, Forecast to 2027

Code: RW00014747635
Multimarket Insight
Jul-2022
Life Sciences
159 Pages

Next-generation sequencing (NGS), also known as massively parallel sequencing, represents an effective way to capture a large amount of genomic information about a cancer. Most NGS technologies revolve around sequencing by synthesis.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.

Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Next Generation Cancer Diagnostic Devices industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.

Market Segment by Product Type
Next Generation Sequencing
qPCR & Multiplexing
Lab-on- a- chip (LOAC)
Protein Microarrays
DNA Microarrays
Reverse Transcriptase-PCR (RT-PCR)

Market Segment by Product Application
Biomarker Development
CTC Analysis
Proteomic Analysis
Epigenetic Analysis
Genetic Analysis

Finally, the report provides detailed profile and data information analysis of leading company.
Roche Holding Ltd. (Switzerland)
Abbott Laboratories(US)
Siemens Healthcare(Germany)
Agilent Technologies Inc(Germany)
Illumina Inc.(US)
Becton Dickinson and Co.(US)
QIAGEN N.V.(Germany)
Affymetrix Inc.(US)
Johnson & Johnson(US)
Thermo Fisher Scientific Inc.(US)
GE Healthcare(England)
Life Technologies Corp.(US)
Luminex Corp.(US)
Cepheid Inc.(US)
Allegro Diagnostics Corp.(Brazil)

Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.

Research Objectives
1.To study and analyze the global Next Generation Cancer Diagnostic Devices consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Next Generation Cancer Diagnostic Devices market by identifying its various subsegments.
3.Focuses on the key global Next Generation Cancer Diagnostic Devices manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Next Generation Cancer Diagnostic Devices with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Next Generation Cancer Diagnostic Devices submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

Global Next Generation Cancer Diagnostic Devices Market Research Report 2022, Forecast to 2027

1 Market Study Overview
1.1 Study Objectives
1.2 Next Generation Cancer Diagnostic Devices Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation

2 Global Trend Summary
2.1 Next Generation Cancer Diagnostic Devices Segment by Type
2.1.1 Next Generation Sequencing
2.1.2 qPCR & Multiplexing
2.1.3 Lab-on- a- chip (LOAC)
2.1.4 Protein Microarrays
2.1.5 DNA Microarrays
2.1.6 Reverse Transcriptase-PCR (RT-PCR)
2.2 Market Analysis by Application
2.2.1 Biomarker Development
2.2.2 CTC Analysis
2.2.3 Proteomic Analysis
2.2.4 Epigenetic Analysis
2.2.5 Genetic Analysis
2.3 Global Next Generation Cancer Diagnostic Devices Market Comparison by Regions (2017-2027)
2.3.1 Global Next Generation Cancer Diagnostic Devices Market Size (2017-2027)
2.3.2 North America Next Generation Cancer Diagnostic Devices Status and Prospect (2017-2027)
2.3.3 Europe Next Generation Cancer Diagnostic Devices Status and Prospect (2017-2027)
2.3.4 China Next Generation Cancer Diagnostic Devices Status and Prospect (2017-2027)
2.3.5 Japan Next Generation Cancer Diagnostic Devices Status and Prospect (2017-2027)
2.3.6 Southeast Asia Next Generation Cancer Diagnostic Devices Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Next Generation Cancer Diagnostic Devices Industry Impact
2.5.1 Next Generation Cancer Diagnostic Devices Business Impact Assessment - Covid-19
2.5.2 Market Trends and Next Generation Cancer Diagnostic Devices Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19

3 Competition by Manufacturer
3.1 Global Next Generation Cancer Diagnostic Devices Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Next Generation Cancer Diagnostic Devices Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Next Generation Cancer Diagnostic Devices Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Next Generation Cancer Diagnostic Devices Manufacturer Market Share
3.5 Top 10 Next Generation Cancer Diagnostic Devices Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Next Generation Cancer Diagnostic Devices Market
3.7 Key Manufacturers Next Generation Cancer Diagnostic Devices Key Manufacturers
3.8 Mergers & Acquisitions Planning

4 Analysis of Next Generation Cancer Diagnostic Devices Industry Key Manufacturers
4.1 Roche Holding Ltd. (Switzerland)
4.1.1 Compan Detail
4.1.2 Roche Holding Ltd. (Switzerland) Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification
4.1.3 Roche Holding Ltd. (Switzerland) 159 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Roche Holding Ltd. (Switzerland) News
4.2 Abbott Laboratories(US)
4.2.1 Compan Detail
4.2.2 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification
4.2.3 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Roche Holding Ltd. (Switzerland) News
4.3 Siemens Healthcare(Germany)
4.3.1 Compan Detail
4.3.2 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification
4.3.3 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Siemens Healthcare(Germany) News
4.4 Agilent Technologies Inc(Germany)
4.4.1 Compan Detail
4.4.2 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification
4.4.3 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Agilent Technologies Inc(Germany) News
4.5 Illumina Inc.(US)
4.5.1 Compan Detail
4.5.2 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification
4.5.3 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Illumina Inc.(US) News
4.6 Becton Dickinson and Co.(US)
4.6.1 Compan Detail
4.6.2 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification
4.6.3 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Becton Dickinson and Co.(US) News
4.7 QIAGEN N.V.(Germany)
4.7.1 Compan Detail
4.7.2 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification
4.7.3 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Affymetrix Inc.(US)
4.8.1 Compan Detail
4.8.2 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification
4.8.3 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Affymetrix Inc.(US) News
4.9 Johnson & Johnson(US)
4.9.1 Compan Detail
4.9.2 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification
4.9.3 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Johnson & Johnson(US) News
4.10 Thermo Fisher Scientific Inc.(US)
4.10.1 Compan Detail
4.10.2 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification
4.10.3 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Thermo Fisher Scientific Inc.(US) News
4.11 GE Healthcare(England)
4.11.1 Compan Detail
4.11.2 GE Healthcare(England) Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification
4.11.3 GE Healthcare(England) Next Generation Cancer Diagnostic Devices Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 GE Healthcare(England) News
4.12 Life Technologies Corp.(US)
4.12.1 Compan Detail
4.12.2 Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification
4.12.3 Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.12.4 Main Business Overview
4.12.5 Life Technologies Corp.(US) News
4.13 Luminex Corp.(US)
4.13.1 Company Details
4.13.2 Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification
4.13.3 Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.13.4 Main Business Overview
4.13.5 Luminex Corp.(US) News
4.14 Cepheid Inc.(US)
4.14.1 Compan Detail
4.14.2 Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification
4.14.3 Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.14.4 Main Business Overview
4.14.5 Cepheid Inc.(US) News
4.15 Allegro Diagnostics Corp.(Brazil)
4.15.1 Compan Detail
4.15.2 Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification
4.15.3 Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.15.4 Main Business Overview
4.15.5 Allegro Diagnostics Corp.(Brazil) News

5 Global Next Generation Cancer Diagnostic Devices Market Segment by Big Type
5.1 Global Next Generation Cancer Diagnostic Devices Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Next Generation Cancer Diagnostic Devices Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Next Generation Cancer Diagnostic Devices Revenue and Market Share by Big Type (2017-2022)
5.2 Next Generation Sequencing Sales Growth Rate and Price
5.2.1 Global Next Generation Sequencing Sales Growth Rate (2017-2022)
5.2.2 Global Next Generation Sequencing Price (2017-2022)
5.3 qPCR & Multiplexing Sales Growth Rate and Price
5.3.1 Global qPCR & Multiplexing Sales Growth Rate (2017-2022)
5.3.2 Global qPCR & Multiplexing Price (2017-2022)
5.4 Lab-on- a- chip (LOAC) Sales Growth Rate and Price
5.4.1 Global Lab-on- a- chip (LOAC) Sales Growth Rate (2017-2022)
5.4.2 Global Lab-on- a- chip (LOAC) Price (2017-2022)
5.5 Protein Microarrays Sales Growth Rate and Price
5.5.1 Global Protein Microarrays Sales Growth Rate (2017-2022)
5.5.2 Global Protein Microarrays Price (2017-2022)
5.6 DNA Microarrays Sales Growth Rate and Price
5.6.1 Global DNA Microarrays Sales Growth Rate (2017-2022)
5.6.2 Global DNA Microarrays Price (2017-2022)
5.7 Reverse Transcriptase-PCR (RT-PCR) Sales Growth Rate and Price
5.7.1 Global Reverse Transcriptase-PCR (RT-PCR) Sales Growth Rate (2017-2022)
5.7.2 Global Reverse Transcriptase-PCR (RT-PCR) Price (2017-2022)

6 Global Next Generation Cancer Diagnostic Devices Market Segment by Big Application
6.1 Global Next Generation Cancer Diagnostic Devices Sales Market Share by Big Application (2017-2022)
6.2 Biomarker Development Sales Growth Rate (2017-2022)
6.3 CTC Analysis Sales Growth Rate (2017-2022)
6.4 Proteomic Analysis Sales Growth Rate (2017-2022)
6.5 Epigenetic Analysis Sales Growth Rate (2017-2022)
6.6 Genetic Analysis Sales Growth Rate (2017-2022)

7 Global Next Generation Cancer Diagnostic Devices Forecast
7.1 Global Next Generation Cancer Diagnostic Devices Revenue, Sales and Growth Rate (2022-2027)
7.2 Next Generation Cancer Diagnostic Devices Market Forecast by Regions (2022-2027)
7.2.1 North America Next Generation Cancer Diagnostic Devices Market Forecast (2022-2027)
7.2.2 Europe Next Generation Cancer Diagnostic Devices Market Forecast (2022-2027)
7.2.3 China Next Generation Cancer Diagnostic Devices Market Forecast (2022-2027)
7.2.4 Japan Next Generation Cancer Diagnostic Devices Market Forecast (2022-2027)
7.2.5 Southeast Asia Next Generation Cancer Diagnostic Devices Market Forecast (2022-2027)
7.2.6 Other Regions Next Generation Cancer Diagnostic Devices Market Forecast (2022-2027)
7.3 Next Generation Cancer Diagnostic Devices Market Forecast by Type (2022-2027)
7.3.1 Global Next Generation Cancer Diagnostic Devices Sales Forecast by Type (2022-2027)
7.3.2 Global Next Generation Cancer Diagnostic Devices Market Share Forecast by Type (2022-2027)
7.4 Next Generation Cancer Diagnostic Devices Market Forecast by Application (2022-2027)
7.4.1 Global Next Generation Cancer Diagnostic Devices Sales Forecast by Application (2022-2027)
7.4.2 Global Next Generation Cancer Diagnostic Devices Market Share Forecast by Application (2022-2027)

8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis

9 Next Generation Cancer Diagnostic Devices Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Next Generation Cancer Diagnostic Devices Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers

10 Research Findings and Conclusion

List of Tables and Figures

Figure Product Picture Next Generation Cancer Diagnostic Devices
Figure Market Concentration Ratio and Market Maturity Analysis of Next Generation Cancer Diagnostic Devices
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Next Generation Cancer Diagnostic Devices Market Size by Big Type
Figure Global Market Share of Next Generation Cancer Diagnostic Devices by Big Type in 2021
Figure Next Generation Sequencing Picture (2017-2022)
Figure qPCR & Multiplexing Picture (2017-2022)
Figure Lab-on- a- chip (LOAC) Picture (2017-2022)
Figure Protein Microarrays Picture (2017-2022)
Figure DNA Microarrays Picture (2017-2022)
Global Next Generation Cancer Diagnostic Devices Market Size by Big Application
Table Global Next Generation Cancer Diagnostic Devices Market Size by Application
Figure Global Next Generation Cancer Diagnostic Devices Market Share by Big Application in 2021
Figure Biomarker Development Picture
Figure CTC Analysis Picture
Figure Proteomic Analysis Picture
Figure Epigenetic Analysis Picture
Figure Genetic Analysis Picture
Table Global Next Generation Cancer Diagnostic Devices Comparison by Regions (M USD) (2017-2027)
Figure Global Next Generation Cancer Diagnostic Devices Market Size (Million US$) (2017-2027)
Figure North America Next Generation Cancer Diagnostic Devices Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Next Generation Cancer Diagnostic Devices Revenue (Million US$) Growth Rate (2017-2027)
Figure China Next Generation Cancer Diagnostic Devices Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Next Generation Cancer Diagnostic Devices Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Next Generation Cancer Diagnostic Devices Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Next Generation Cancer Diagnostic Devices Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Next Generation Cancer Diagnostic Devices Sales by Manufacturer (2017-2022)
Figure Global Next Generation Cancer Diagnostic Devices Sales Market Share by Manufacturer in 2021
Table Global Next Generation Cancer Diagnostic Devices Revenue by Manufacturer (2017-2022)
Figure Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Manufacturer in 2021
Table Global Next Generation Cancer Diagnostic Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Next Generation Cancer Diagnostic Devices Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Next Generation Cancer Diagnostic Devices Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Next Generation Cancer Diagnostic Devices Market
Table Key Manufacturers Next Generation Cancer Diagnostic Devices Product Type
Table Mergers & Acquisitions Planning
Table Roche Holding Ltd. (Switzerland) Company Profile
Table Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification of Roche Holding Ltd. (Switzerland)
Table Next Generation Cancer Diagnostic Devices Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Abbott Laboratories(US) Company Profile
Table Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification of Abbott Laboratories(US)
Table Next Generation Cancer Diagnostic Devices Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Abbott Laboratories(US) Recent Development
Table Siemens Healthcare(Germany) Company Profile
Table Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification of Siemens Healthcare(Germany)
Table Next Generation Cancer Diagnostic Devices Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Siemens Healthcare(Germany) Main Business
Table Siemens Healthcare(Germany) Recent Development
Table Agilent Technologies Inc(Germany) Company Profile
Table Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification of Agilent Technologies Inc(Germany)
Table Next Generation Cancer Diagnostic Devices Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Agilent Technologies Inc(Germany) Main Business
Table Agilent Technologies Inc(Germany) Recent Development
Table Agilent Technologies Inc(Germany) Main Business
Table Agilent Technologies Inc(Germany) Recent Development
Table Illumina Inc.(US) Company Profile
Table Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification of Illumina Inc.(US)
Table Next Generation Cancer Diagnostic Devices Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Illumina Inc.(US) Main Business
Table Illumina Inc.(US) Recent Development
Table Becton Dickinson and Co.(US) Company Profile
Table Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification of Becton Dickinson and Co.(US)
Table Next Generation Cancer Diagnostic Devices Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Becton Dickinson and Co.(US) Main Business
Table Becton Dickinson and Co.(US) Recent Development
Table QIAGEN N.V.(Germany) Company Profile
Table Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification of QIAGEN N.V.(Germany)
Table Next Generation Cancer Diagnostic Devices Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table QIAGEN N.V.(Germany) Main Business
Table QIAGEN N.V.(Germany) Recent Development
Table Affymetrix Inc.(US) Company Profile
Table Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification of Affymetrix Inc.(US)
Table Next Generation Cancer Diagnostic Devices Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Affymetrix Inc.(US) Main Business
Table Affymetrix Inc.(US) Recent Development
Table Johnson & Johnson(US) Company Profile
Table Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification of Johnson & Johnson(US)
Table Next Generation Cancer Diagnostic Devices Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Johnson & Johnson(US) Main Business
Table Johnson & Johnson(US) Recent Development
Table Thermo Fisher Scientific Inc.(US) Company Profile
Table Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification of Thermo Fisher Scientific Inc.(US)
Table Next Generation Cancer Diagnostic Devices Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Thermo Fisher Scientific Inc.(US) Main Business
Table Thermo Fisher Scientific Inc.(US) Recent Development
Table GE Healthcare(England) Company Profile
Table Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification of GE Healthcare(England)
Table Next Generation Cancer Diagnostic Devices Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table GE Healthcare(England) Main Business
Table GE Healthcare(England) Recent Development
Table Life Technologies Corp.(US) Company Profile
Table Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification of Life Technologies Corp.(US)
Table Next Generation Cancer Diagnostic Devices Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Life Technologies Corp.(US) Main Business
Table Life Technologies Corp.(US) Recent Development
Table Luminex Corp.(US) Company Profile
Table Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification of Luminex Corp.(US)
Table Next Generation Cancer Diagnostic Devices Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Luminex Corp.(US) Main Business
Table Luminex Corp.(US) Recent Development
Table Cepheid Inc.(US) Company Profile
Table Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification of Cepheid Inc.(US)
Table Next Generation Cancer Diagnostic Devices Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Cepheid Inc.(US) Main Business
Table Cepheid Inc.(US) Recent Development
Figure Global Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2017-2022)
Figure Global Next Generation Cancer Diagnostic Devices Revenue and Growth Rate (2017-2022)
Table Global Next Generation Cancer Diagnostic Devices Sales by Regions (2017-2022)
Figure Global Next Generation Cancer Diagnostic Devices Sales Market Share by Regions in 2021
Table Global Next Generation Cancer Diagnostic Devices Revenue by Regions (2017-2022)
Figure Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Regions in 2021
Figure North America Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2017-2022)
Figure Europe Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2017-2022)
Figure China Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2017-2022)
Figure Japan Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2017-2022)
Figure Southeast Asia Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2017-2022)
Figure Other Regions Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2017-2022)
Table Global Next Generation Cancer Diagnostic Devices Sales by Big Type (2017-2022)
Table Global Next Generation Cancer Diagnostic Devices Sales Market Share by Big Type (2017-2022)
Figure Global Next Generation Cancer Diagnostic Devices Sales Market Share by Big Type in 2019
Table Global Next Generation Cancer Diagnostic Devices Revenue by Big Type (2017-2022)
Table Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Big Type (2017-2022)
Table Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Big Type in 2019
Figure Global Next Generation Sequencing Sales Growth Rate (2017-2022)
Figure Global Next Generation Sequencing Price (2017-2022)
Figure Global qPCR & Multiplexing Sales Growth Rate (2017-2022)
Figure Global qPCR & Multiplexing Price (2017-2022)
Figure Global Lab-on- a- chip (LOAC) Sales Growth Rate (2017-2022)
Figure Global Lab-on- a- chip (LOAC) Price (2017-2022)
Figure Global Protein Microarrays Sales Growth Rate (2017-2022)
Figure Global Protein Microarrays Price (2017-2022)
Figure Global Reverse Transcriptase-PCR (RT-PCR) Sales Growth Rate (2017-2022)
Table Global Next Generation Cancer Diagnostic Devices Sales by Big Application (2017-2022)
Table Global Next Generation Cancer Diagnostic Devices Sales Market Share by Big Application (2017-2022)
Figure Global Next Generation Cancer Diagnostic Devices Sales Market Share by Big Application in 2019
Figure Global Biomarker Development Sales Growth Rate (2017-2022)
Figure Global CTC Analysis Sales Growth Rate (2017-2022)
Figure Global Proteomic Analysis Sales Growth Rate (2017-2022)
Figure Global Epigenetic Analysis Sales Growth Rate (2017-2022)
Figure Global Genetic Analysis Sales Growth Rate (2017-2022)
Figure Global Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2022-2027)
Figure Global Next Generation Cancer Diagnostic Devices Revenue and Growth Rate (2022-2027)
Table Global Next Generation Cancer Diagnostic Devices Sales Forecast by Regions (2022-2027)
Table Global Next Generation Cancer Diagnostic Devices Market Share Forecast by Regions (2022-2027)
Figure North America Sales Next Generation Cancer Diagnostic Devices Market Forecast (2022-2027)
Figure Europe Sales Next Generation Cancer Diagnostic Devices Market Forecast (2022-2027)
Figure China Sales Next Generation Cancer Diagnostic Devices Market Forecast (2022-2027)
Figure Japan Sales Next Generation Cancer Diagnostic Devices Market Forecast (2022-2027)
Figure Southeast Asia Sales Next Generation Cancer Diagnostic Devices Market Forecast (2022-2027)
Figure Other Regions Sales Next Generation Cancer Diagnostic Devices Market Forecast (2022-2027)
Table Global Next Generation Cancer Diagnostic Devices Sales Forecast by Type (2022-2027)
Table Global Next Generation Cancer Diagnostic Devices Market Share Forecast by Type (2022-2027)
Table Global Next Generation Cancer Diagnostic Devices Sales Forecast by Application (2022-2027)
Table Global Next Generation Cancer Diagnostic Devices Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Next Generation Cancer Diagnostic Devices
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Next Generation Cancer Diagnostic Devices Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Next Generation Cancer Diagnostic Devices Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Next Generation Cancer Diagnostic Devices Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Next Generation Cancer Diagnostic Devices Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Next Generation Cancer Diagnostic Devices Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Next Generation Cancer Diagnostic Devices Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Next Generation Cancer Diagnostic Devices Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Next Generation Cancer Diagnostic Devices Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List

Roche Holding Ltd. (Switzerland)
Abbott Laboratories(US)
Siemens Healthcare(Germany)
Agilent Technologies Inc(Germany)
Illumina Inc.(US)
Becton Dickinson and Co.(US)
QIAGEN N.V.(Germany)
Affymetrix Inc.(US)
Johnson & Johnson(US)
Thermo Fisher Scientific Inc.(US)
GE Healthcare(England)
Life Technologies Corp.(US)
Luminex Corp.(US)

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE